Cargando…
Estimating complete cancer prevalence in Europe: validity of alternative vs standard completeness indexes
INTRODUCTION: Comparable indicators on complete cancer prevalence are increasingly needed in Europe to support survivorship care planning. Direct measures can be biased by limited registration time and estimates are needed to recover long term survivors. The completeness index method, based on incid...
Autores principales: | Demuru, Elena, Rossi, Silvia, Ventura, Leonardo, Dal Maso, Luigino, Guzzinati, Stefano, Katalinic, Alexander, Lamy, Sebastien, Jooste, Valerie, Di Benedetto, Corrado, De Angelis, Roberta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166634/ https://www.ncbi.nlm.nih.gov/pubmed/37168378 http://dx.doi.org/10.3389/fonc.2023.1114701 |
Ejemplares similares
-
Projecting cancer prevalence by phase of care: a methodological approach for health service planning
por: Francisci, Silvia, et al.
Publicado: (2023) -
Complete prevalence and indicators of cancer cure: enhanced methods and validation in Italian population-based cancer registries
por: Toffolutti, Federica, et al.
Publicado: (2023) -
Tackling Thyroid Cancer in Europe—The Challenges and Opportunities
por: Horgan, Denis, et al.
Publicado: (2022) -
Thyroid cancer “epidemic” also occurs in low‐ and middle‐income countries
por: Lortet‐Tieulent, Joannie, et al.
Publicado: (2018) -
Comment on ‘Anthropometric measurements and survival after prostate cancer diagnosis’
por: Dal Maso, Luigino, et al.
Publicado: (2018)